Mutoloki Stephen, Munang'andu Hetron Mweemba, Evensen Øystein
Department of Basic Sciences and Aquatic Medicine, Faculty of Veterinary Medicine and Biosciences, Norwegian University of Life Sciences , Oslo , Norway.
Front Immunol. 2015 Oct 19;6:519. doi: 10.3389/fimmu.2015.00519. eCollection 2015.
The oral route offers the most attractive approach of immunization of fish for a number of reasons: the ease of administration of antigens, it is less stressful than parenteral delivery and in principle, it is applicable to small and large sized fish; it also provides a procedure for oral boosting during grow-out periods in cages or ponds. There are, however, not many commercial vaccines available at the moment due to lack of efficacy and challenges associated with production of large quantities of antigens. These are required to stimulate an effective immune response locally and systemically, and need to be protected against degradation before they reach the sites where immune induction occurs. The hostile stomach environment is believed to be particularly important with regard to degradation of antigens in certain species. There is also a poor understanding about the requirements for proper immune induction following oral administration on one side, and the potential for induction of tolerance on the other. To what extent primary immunization via the oral route will elicit both local and systemic responses is not understood in detail. Furthermore, to what extent parenteral delivery will protect mucosal/gut surfaces and vice-versa is also not fully understood. We review the work that has been done on the subject and discuss it in light of recent advances that include mass production of antigens, including the use of plant systems. Different encapsulation techniques that have been developed in the quest to protect antigens against digestive degradation, as well as to target them for appropriate immune induction are also highlighted.
由于多种原因,口服途径为鱼类免疫提供了最具吸引力的方法:抗原易于施用,比肠胃外给药压力小,原则上适用于大小鱼类;它还为网箱或池塘养殖期的口服加强免疫提供了一种方法。然而,由于缺乏效力以及与大量抗原生产相关的挑战,目前可用的商业疫苗并不多。这些抗原需要在局部和全身刺激有效的免疫反应,并且在到达免疫诱导发生的部位之前需要防止降解。在某些物种中,恶劣的胃部环境被认为对抗原降解尤为重要。一方面,对于口服给药后适当免疫诱导的要求了解不足,另一方面,对于诱导耐受性的可能性也了解不足。通过口服途径进行初次免疫在多大程度上会引发局部和全身反应尚不清楚。此外,肠胃外给药在多大程度上会保护粘膜/肠道表面,反之亦然,也尚未完全了解。我们回顾了在该主题上已完成的工作,并根据包括抗原大规模生产(包括使用植物系统)在内的最新进展进行讨论。还强调了为保护抗原免受消化降解以及将其靶向进行适当免疫诱导而开发的不同包封技术。